Letter: Early autoantibody formation in lethally irradiated or drug-treated H-2-compatible recipients of pre-autoimmune NZB bone marrow or fetal liver cells.
D000818:Animals; D000974:Antibodies, Antinuclear; D000917:Antibody Formation; D001323:Autoantibodies; D001853:Bone Marrow / Q000276:immunology* / Q000528:radiation effects; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology; D006410:Hematopoiesis / Q000187:drug effects / Q000528:radiation effects; D006648:Histocompatibility; D008099:Liver / Q000276:immunology* / Q000528:radiation effects; D016031:Liver Transplantation; D051379:Mice; D008807:Mice, Inbred BALB C; D008811:Mice, Inbred DBA; D008814:Mice, Inbred NZB; D011830:Radiation Effects; D014181:Transplantation Immunology
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D003520:Cyclophosphamide; D002066:Busulfan